MK-8150

MK-8150 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-8150, covering 2016-04-29 to 2016-06-27. Get the full timeline:

Most recent: Clinical Trial Update: A Single Rising Dose Study of MK-8150 (MK-8150-001) [Phase 1]